Levosimendan: a new option in acute cardiac failure

Emerg Med Australas. 2006 Oct-Dec;18(5-6):505-9. doi: 10.1111/j.1742-6723.2006.00871.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Biological Availability
  • Cardiotonic Agents / adverse effects
  • Cardiotonic Agents / pharmacokinetics
  • Cardiotonic Agents / pharmacology
  • Cardiotonic Agents / therapeutic use*
  • Heart Failure / drug therapy*
  • Humans
  • Hydrazones / adverse effects
  • Hydrazones / pharmacokinetics
  • Hydrazones / pharmacology
  • Hydrazones / therapeutic use*
  • Pyridazines / adverse effects
  • Pyridazines / pharmacokinetics
  • Pyridazines / pharmacology
  • Pyridazines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Simendan

Substances

  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Simendan